Survival of COVID-19 with Multimorbidity Patients
Background: The outbreak of SARS-CoV-2 abruptly disseminated in early 2020, overcoming the capacity of health systems to respond the pandemic. It was not until the vaccines were launched worldwide that an increase in survival was observed. The objectives of this study were to analyse the characteris...
Enregistré dans:
Auteurs principaux: | E. Bustos-Vázquez, E. Padilla-González, D. Reyes-Gómez, M. C. Carmona-Ramos, J. A. Monroy-Vargas, A. E. Benítez-Herrera, G. Meléndez-Mier |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/0142f979c0ec45bc8cdce947111feb7f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
par: Ravi Kant, et autres
Publié: (2021) -
An Observational Study on Patients with Acute Limb Ischemia and SARS-CoV-2 Infection: Early and Late Results in Limb Salvage Rate
par: Sorin Barac, et autres
Publié: (2021) -
COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
par: Lea Hsu, et autres
Publié: (2021) -
Can a Nasal/Oral/Ocular Spray Inactivate and Prevent SARS-CoV-2 infection? A hypothesis
par: Fuentes,Edgardo, et autres
Publié: (2020) -
Changing Features of COVID-19: Characteristics of Infections with the SARS-CoV-2 Delta (B.1.617.2) and Alpha (B.1.1.7) Variants in Southern Italy
par: Daniela Loconsole, et autres
Publié: (2021)